Penthrox approved in Hungary
25 May 2020
ASX Announcement
Penthrox approved in Hungary
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Hungary. The Marketing Authorisation issued by the National Institute of Pharmacy and Nutrition (OGYÉI), is for Penthrox® to be used for emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.
The approval in Hungary is part of a set of four countries. Bosnia & Herzegovina were approved earlier this month, and approvals for Greece and Malta are expected soon.
Whilst both the European Decentralised Procedure and the National phase is complete, Penthrox is yet to achieve government reimbursement in Hungary. However sales can be made to the private market immediately.
Authorised for release by MVP Company Secretary, Mark Edwards.